Read the latest news stories in diabetes tech, research and innovation.
News
+3
/
Oct 29, 2025
All U.S. t:slim X2 users have access to FreeStyle Libre 3 Plus CGM integration, with international early-access programs rolling out later this year.
+1
New laws and state-run manufacturing aim to make insulin more affordable to all Californians starting in 2026, setting a national example for diabetes care reform.
Dexcom
+2
Oct 28, 2025
A California parent says Dexcom’s G7 continuous glucose monitor gave false readings and missed life-saving alerts, sparking a class action and renewed concerns over CGM safety.
Oct 15, 2025
The move to end research into a potential type 1 diabetes cure has left many people with diabetes frustrated, reflective, and still holding on to hope.
Oct 14, 2025
The FDA has accepted MannKind’s application to expand the use of its inhaled insulin, Afrezza, to children, marking a key step toward potential pediatric approval.
CGM
Oct 7, 2025
Biolinq’s Shine biosensor uses needle-free technology and real-time LED feedback to track glucose for people with type 2 diabetes.
Roche’s latest integration brings AI-driven glucose predictions, personalized logging, and easy data sharing into one connected platform.
+4
Sep 30, 2025
FDA clears Tandem’s t:slim X2 insulin pump for use with Lilly’s ultra-rapid Lyumjev insulin, expanding options beyond Humalog and Novolog.
Sep 25, 2025
We got an early look the upcoming Trends tab coming to Dexcom G7, which brings food, exercise, insulin, and glucose data into one dashboard — rolling out soon in the U.S.
Sep 24, 2025
We got a first look at the FDA-cleared 7-day SteadiSet infusion set coming to all Tandem pumps in the U.S next year.
Future Tech
Sep 15, 2025
This continuous glucose monitor promises multi-sensor health tracking and is aiming for a mid-2026 launch
Sep 4, 2025
The latest Series A funding brings Luna's bedtime patch pump, for MDI users, one step closer to reality.
Medtronic
+5
Sep 2, 2025
Medtronic's SmartGuard algorithm is cleared for the upcoming 15-day Instinct CGM and the MiniMed 780G gets clearance for type 2 diabetes.
Aug 27, 2025
London startup Sava reports early results from its non-invasive sensor, backed by $19M in new funding.
+9
Aug 26, 2025
The future of insulin delivery is tubeless, screenless, phoneless—and even movement-tracking. Here are the devices in development you need to know about.
Aug 22, 2025
ViCentra brings smartphone control and Dexcom G7 integration to Kaleido, powered by Diabeloop’s DBLG2 algorithm.
Aug 18, 2025
Tandem’s SteadiSet 7-day infusion set received FDA 510(k) clearance and is expected to release on multiple pumps next year.
Aug 11, 2025
Medtronic's new CGM built by Abbott is 510(k) pending and under FDA review, signaling major changes ahead for MiniMed insulin pumps.
Jul 29, 2025
The tubeless add-on for Tandem's Mobi insulin pump will give users an untethered wear option and challenge competitors to innovate faster.
Jul 22, 2025
Tandem’s SteadiSet received FDA 510(k) clearance for 7-day wear and is expected to release in 2026 for multiple pumps.
Jul 21, 2025
I speak with Dexcom about recent sensor failures and receiver recalls, how the company is responding, and what’s next—including new G7 app features and the upcoming 15-day sensor.
Jul 17, 2025
The star of Black-ish opens up about his diabetes journey and shares how laughter—and a little technology—can go a long way.
Jul 8, 2025
From tubeless pumps to a dual glucose-ketone sensor and cell therapy breakthroughs—ADA 2025 delivered game-changing updates in diabetes tech. Here's what stood out.
Jun 25, 2025
A new CGM deal moves PharmaSens one step closer to creating a fully self-contained insulin pump and CGM.
Jun 24, 2025
The pump currently in development allows users to change sites without a phone—potentially reshaping the tubeless landscape and pushing rivals to move faster.
